Announced
Completed
Synopsis
IMCD, a distributor of specialty chemicals and food ingredients, completed the acquisition of DCS Pharma, a Swiss pharmaceutical distributor. Financial terms were not disclosed. With this acquisition, IMCD acquired 90% of the shares in DCS Pharma. The remaining 10% will follow per 31 December 2021. “DCS is a significant acquisition for the development of our Pharmaceutical business, not only in expanding our global footprint, but moreover in exploiting the clear pipeline, formulation and marketing synergies between Active Pharmaceutical Ingredients and Excipients,’’ John Robinson, IMCD Business Group Director Pharmaceuticals.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.